Extra-Pancreatic Neuroendocrine Tumor (epNET) trials recruiting in Nebraska

Fewer than 3 recruiting trials found.

All Extra-Pancreatic Neuroendocrine Tumor (epNET) trials nationally

Cities in Nebraska

Recruiting trials in Nebraska

• Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
  NCT06943755 · Phase: Phase 2, Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Nebraska: Omaha